These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 9516895)

  • 41. Influence of breathing pattern on lung deposition and bronchodilator response to nebulised salbutamol in patients with stable asthma.
    Zainudin BM; Tolfree SE; Short M; Spiro SG
    Thorax; 1988 Dec; 43(12):987-91. PubMed ID: 3238642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma.
    Smyth ET; Pavord ID; Wong CS; Wisniewski AF; Williams J; Tattersfield AE
    BMJ; 1993 Feb; 306(6877):543-5. PubMed ID: 8096416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The biochemical effects of high-dose inhaled salbutamol in patients with asthma.
    Lipworth BJ; Clark RA; Fraser CG; McDevitt DG
    Eur J Clin Pharmacol; 1989; 36(4):357-60. PubMed ID: 2737227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-Dose Inhaled Salbutamol Does Not Improve 10-km Cycling Time Trial Performance.
    Koch S; Ahn JR; Koehle MS
    Med Sci Sports Exerc; 2015 Nov; 47(11):2373-9. PubMed ID: 25856682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of airway calibre on the intrapulmonary dose and distribution of inhaled aerosol in normal and asthmatic subjects.
    Chung KF; Jeyasingh K; Snashall PD
    Eur Respir J; 1988 Dec; 1(10):890-5. PubMed ID: 3066640
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Airway responsiveness to beta-adrenergic agonist (salbutamol) in asthma.
    Boskabady MH; Saadatinejad M
    J Asthma; 2003 Dec; 40(8):917-25. PubMed ID: 14736092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of the clinical efficacy and patient acceptability of terbutaline Turbuhaler and salbutamol Rotahaler, in adult patients with asthma.
    Gioulekas D; Papakosta D; Vordoyianni P; Baloti H; Vamvalis C
    Respir Med; 1996 Apr; 90(4):205-9. PubMed ID: 8736653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhaled procaterol versus salbutamol in bronchial asthma.
    Liippo K; Silvasti M; Tukiainen H
    Eur J Clin Pharmacol; 1991; 40(4):417-8. PubMed ID: 1828765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma.
    Wallin A; Sandström T; Rosenhall L; Melander B
    Thorax; 1993 Jun; 48(6):611-4. PubMed ID: 8346490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous beta agonist in severe acute asthma.
    Cheong B; Reynolds SR; Rajan G; Ward MJ
    BMJ; 1988 Aug; 297(6646):448-50. PubMed ID: 3139138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group.
    van Essen-Zandvliet EE; Hughes MD; Waalkens HJ; Duiverman EJ; Pocock SJ; Kerrebijn KF
    Am Rev Respir Dis; 1992 Sep; 146(3):547-54. PubMed ID: 1355640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma.
    Higham MA; Sharara AM; Wilson P; Jenkins RJ; Glendenning GA; Ind PW
    Thorax; 1997 Nov; 52(11):975-80. PubMed ID: 9487346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma.
    Wong CS; Pavord ID; Williams J; Britton JR; Tattersfield AE
    Lancet; 1990 Dec; 336(8728):1396-9. PubMed ID: 1978872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective subsensitization of beta-adrenergic receptors in central airways of asthmatics and normal subjects during long-term therapy with inhaled salbutamol.
    Conolly ME; Tashkin DP; Hui KK; Littner MR; Wolfe RN
    J Allergy Clin Immunol; 1982 Dec; 70(6):423-31. PubMed ID: 6292279
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alternative functional criteria to assess airflow-limitation reversibility in asthma.
    Tavares e Castro A; Matos P; Tavares B; Matos MJ; Segorbe-Luís A
    Rev Port Pneumol (2006); 2015; 21(2):69-75. PubMed ID: 25926369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Three 20-minute interspaced salbutamol inhalations as a test for the diagnosis of reversible airflow limitation in adult asthmatics.
    Tomari S; Matsuse H; Machida I; Kondo Y; Kawano T; Obase Y; Fukushima C; Shimoda T; Kohno S
    J Asthma; 2004 Feb; 41(1):43-8. PubMed ID: 15046377
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma.
    Patel M; Pilcher J; Reddel HK; Qi V; Mackey B; Tranquilino T; Shaw D; Black P; Weatherall M; Beasley R;
    J Allergy Clin Immunol Pract; 2014; 2(6):751-8. PubMed ID: 25439367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.
    Lundback B; Rawlinson DW; Palmer JB
    Thorax; 1993 Feb; 48(2):148-53. PubMed ID: 8493629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Salbutamol and high-intensity treadmill running in nonasthmatic highly conditioned athletes.
    Heir T; Stemshaug H
    Scand J Med Sci Sports; 1995 Aug; 5(4):231-6. PubMed ID: 7552768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of single doses of S-salbutamol, R-salbutamol, racemic salbutamol, and placebo on the airway response to methacholine.
    Cockcroft DW; Swystun VA
    Thorax; 1997 Oct; 52(10):845-8. PubMed ID: 9404369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.